TD Waterhouse Canada’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$113K Sell
2025
Q2
$83.4K Buy
2025
Q1
$37.1K Buy
2024
Q4
$41.1K Sell
2024
Q3
$59.7K Hold
2024
Q2
$70.7K Buy
2024
Q1
$85.3K Sell
2023
Q4
$90.7K Sell
2023
Q3
$65.7K Sell
2023
Q2
$87.3K Sell
2023
Q1
$80.5K Sell
2022
Q4
$76.4K Sell
2022
Q3
$128K Sell
2022
Q2
$273K Buy
2022
Q1
$277K Buy
2021
Q4
$115K Buy